PENTAX Medical Introduces New Updates to C2 CryoBalloon™ Product Line
1. 180° C2 CryoBalloon™ Catheter for Barrett's Esophagus:
- Increased Treatment Area and Efficiency: The 180° C2 CryoBalloon Catheter is the first cryogenic product specifically designed to treat large areas of Barrett's esophagus. The unique 180° design allows gastroenterologists to cover larger areas quickly, reducing the overall procedure time. This establishes the C2 CryoBalloon 180° as an ablative therapy that treats large tissue areas, minimizes patient discomfort, and demonstrates 90% disease regression at the first surveillance visit.
2. New Clinical Indication for Gastric Antral Vascular Ectasia (GAVE):
- Less Painful Treatment Option: The C2 CryoBalloon solution now offers a novel treatment for GAVE. This minimally invasive cryogenic technology proves to be a less painful alternative to existing available treatment. C2 CryoBalloon System targets affected areas with quick precise cryotherapy, minimizing the need for frequent packed red blood cell transfusions at 6 months when compared to existing treatment modalities.
- FDA Clearance: PENTAX Medical has obtained FDA clearance for the use of the C2 CryoBalloon system in treating GAVE. This clearance confirms the system's safety and efficacy, offering gastroenterologists a new tool to enhance patient care.
"The introduction of the 180° C2 CryoBalloon Catheter and the new indication for GAVE treatment represent significant advancements in patient care." This was emphasized by
For more information, please visit www.pentaxmedical.com/us.
About PENTAX Medical
PENTAX Medical is a division of HOYA Group. The company's mission is to improve the standard of patient care and quality of healthcare delivery by providing the best endoscopic products and services with a focus on QUALITY, CLINICALLY RELEVANT INNOVATION, and SIMPLICITY.
PENTAX Medical strives to align with the healthcare community's Triple Aim goals through transparent partnerships with its customers and by providing the highest quality solutions to help them reach their goals, including enabling customers to improve patient outcomes by offering evidence-based solutions across the continuum of care; ensuring value by supporting the customers to improve their efficiency and minimize their healthcare costs; and enriching patient and provider's experience by empowering every member of the care team to achieve optimal outcomes through products, education, and support.
Focused on the outcome instead of technological features, PENTAX Medical listens to the healthcare community and their patients, understands their daily obstacles and helps improve endoscopy with smart innovations.
For more information: http://www.pentaxmedical.com
About HOYA
Founded in 1941 in Tokyo,
View original content to download multimedia:https://www.prnewswire.com/news-releases/pentax-medical-introduces-new-updates-to-c2-cryoballoon-product-line-302213803.html
SOURCE PENTAX Medical
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Willamette Valley Vineyards Posts Results for Q2 2026
- Hyundai Motor Group and KIRARA Release 'Temper,' a Musical Interpretation of Technological Refinement
- MetaOptics to Deploy its Direct Laser Writer at the nano@stanford Facility
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share